课题基金 / 基金详情

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

Integrated Stepped Care for Unhealthy Alcohol Use in HIV
针对艾滋病毒不健康饮酒的综合分级护理
批准号:
8332274
负责人:
David Fiellin
金额:
$60.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-15 至 2016-08-31

项目摘要

项目成果

David Fiellin的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Unhealthy alcohol use threatens the health benefits seen with antiretroviral therapy (ART) for HIV-infected (HIV+) patients. Although research has demonstrated the efficacy of brief interventions, motivational counseling, and medications to treat unhealthy alcohol use in HIV unifected patients, there is limited research or use of these treatments in HIV+ patients. We have demonstrated that integrated treatment of addiction in HIV clinics is feasible. Stepped care algorithms can facilitate the evaluation of varying intensities of treatments for unhealthy alcohol use:~The proposed study will compare onsite Integrated Stepped Care treatment (ISC) to treatment as usual (TAU) in three, linked, 6-month randomized clinical trails in 642 HIV+ patients with unhealthy alcohol use. Screened patients are randomized to ISC or TAU after determining that they meet criteria for either 1) at-risk drinking, 2) alcohol abuse or dependence or 3) moderate alcohol consumption in the presence of liver disease. ISC and TAU are tailored to the drinking category. ISC for at- risk drinkers and those with moderate alcohol use and liver disease begins with a brief intervention and is stepped up to Motivational Enhancement Therapy (MET) in those who meet predefined failure criteria. ISC for abuse or dependence begins with addiction psychiatrist management (ARM) including alcohol pharmacotherapy if not contraindicated. ARM is stepped up to include MET if predefined failure criteria are met. The study will test the hypothesis that ISC leads to decreased alcohol consumption and improved HIV biomarkers. Data analyses will be conducted on the intention to treat sample. The primary outcome is change in alcohol consumption assessed by self report. Secondary outcomes include change in the VACS Index, ART adherence, and sexual risk behaviors. Novel aspects of this proposal include: 1) Integrated alcohol and HIV treatment; 2) Stepped care; 3) The use of the VACS Index as an expanded HIV biomarker and 4) Participation in COMpAAAS. The proposed study, conducted by an experienced team of HIV and addiction researchers, will help define the role of ISC HIV+ with unhealthy alcohol use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prazosin Treatment for Alcohol Use Disorder with Alcohol Withdrawal Symptoms
  • 批准号:
    10183652
  • 项目类别:
  • 资助金额:
    $74.77万
  • 财政年份:
    2021
  • 负责人:
    David Fiellin
  • 依托单位:
Prazosin Treatment for Alcohol Use Disorder with Alcohol Withdrawal Symptoms
  • 批准号:
    10582713
  • 项目类别:
  • 资助金额:
    $71.78万
  • 财政年份:
    2021
  • 负责人:
    David Fiellin
  • 依托单位:
Prazosin Treatment for Alcohol Use Disorder with Alcohol Withdrawal Symptoms
  • 批准号:
    10403666
  • 项目类别:
  • 资助金额:
    $73.43万
  • 财政年份:
    2021
  • 负责人:
    David Fiellin
  • 依托单位:
Safety and Comparative Effectiveness of New Medications for Unhealthy Alcohol Use in HIV
  • 批准号:
    8840795
  • 项目类别:
  • 资助金额:
    $41.42万
  • 财政年份:
    2015
  • 负责人:
    David Fiellin
  • 依托单位: